These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679
446 results:

  • 1. Preliminary results of Polish national multicenter LILEO study on ileostomy reversal.
    Kisielewski M; Wysocki M; Stefura T; Wojewoda T; Safiejko K; Wierdak M; Sachanbiński T; Jankowski M; Tkaczyński K; Richter K; Wysocki W
    Pol Przegl Chir; 2024 Feb; 96(3):26-31. PubMed ID: 38940251
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. BATF promotes tumor progression and association with FDG PET-derived parameters in colorectal cancer.
    Lu X; Liu J; Feng L; Huang Y; Xu Y; Li C; Wang W; Kan Y; Yang J; Zhang M
    J Transl Med; 2024 Jun; 22(1):558. PubMed ID: 38862971
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Predictive value of 18F-fluorodeoxyglucose PET/CT in histological grade of incidental colorectal adenoma.
    Peng Y; Xu N; Fu Y; Wang L; Chen F; Xue B; Lan J; Zheng X; Tang K
    Q J Nucl Med Mol Imaging; 2024 Jun; 68(2):143-151. PubMed ID: 38860275
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic Significance of Synchronous colorectal Adenocarcinoma: A Matched-Pair Analysis.
    Anannamcharoen S; Nimmanon T; Cheeranont P; Boonya-Ussadorn C
    Asian Pac J Cancer Prev; 2024 May; 25(5):1539-1545. PubMed ID: 38809625
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Targeting CEACAM5-positive solid tumors using NILK-2401, a novel CEACAM5xCD47 κλ bispecific antibody.
    Seckinger A; Buatois V; Moine V; Daubeuf B; Richard F; Chatel L; Viandier A; Bosson N; Rousset E; Masternak K; Salgado-Pires S; Batista C; Mougin C; Juan-Bégeot F; Poitevin Y; Hose D
    Front Immunol; 2024; 15():1378813. PubMed ID: 38720892
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Comparison of 68 Ga-FAPI-04 PET/CT with 18 F-FDG PET/CT for diagnosis and staging of gastric and colorectal cancer.
    Wang B; Zhao X; Liu Y; Zhang Z; Chen X; Jing F; Chen X; Hua Y; Zhao J
    Nucl Med Commun; 2024 Jul; 45(7):612-621. PubMed ID: 38686487
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Prospects of qualitative and quantitative assessment of bowel perfusion by fluorescent angiography with indocyanine green in colorectal surgery. First experience].
    Kashchenko VA; Dzhemilova ZN; Zavrazhnov AA; Ratnikov VA; Bogatikov AA; Petrova VV; Guschina OB
    Khirurgiia (Mosk); 2024; (4):82-92. PubMed ID: 38634589
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Interaction of the chemotherapeutic agent oxaliplatin and the tyrosine kinase inhibitor dasatinib with the organic cation transporter 2.
    Ahmed Eltayeb S; Dressler JM; Schlatt L; Pernecker M; Neugebauer U; Karst U; Ciarimboli G
    Arch Toxicol; 2024 Jul; 98(7):2131-2142. PubMed ID: 38589558
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Synthesis and characterisation of a nucleotide based pro-drug formulated with a peptide into a nano-chemotherapy for colorectal cancer.
    Wilson JJ; Bennie L; Eguaogie O; Elkashif A; Conlon PF; Jena L; McErlean E; Buckley N; Englert K; Dunne NJ; Tucker JHR; Vyle JS; McCarthy HO
    J Control Release; 2024 May; 369():63-74. PubMed ID: 38513729
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC-1 study design.
    Groarke JD; Crawford J; Collins SM; Lubaczewski SL; Breen DM; Harrington MA; Jacobs I; Qiu R; Revkin J; Rossulek MI; Saxena AR
    J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):1054-1061. PubMed ID: 38500292
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin Coadministration.
    Piscitelli J; Reddy MB; Wollenberg L; Del Frari L; Gong J; Wood L; Zhang Y; Matschke K; Williams JH
    Clin Pharmacokinet; 2024 Apr; 63(4):483-496. PubMed ID: 38424308
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Factors associated with sexual dysfunction in patients with colorectal cancer in Iran: a cross-sectional study.
    Dahouri A; Sahebihagh MH; Gilani N
    Sci Rep; 2024 Feb; 14(1):4915. PubMed ID: 38418573
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Ureter Metastasis From colorectal cancer Revealed on 18 F-FDG PET/CT.
    Zhang J; Yang L; Wei L; Guo Z; Xie P
    Clin Nucl Med; 2024 May; 49(5):478-480. PubMed ID: 38409759
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. End-to-end prognostication in colorectal cancer by deep learning: a retrospective, multicentre study.
    Jiang X; Hoffmeister M; Brenner H; Muti HS; Yuan T; Foersch S; West NP; Brobeil A; Jonnagaddala J; Hawkins N; Ward RL; Brinker TJ; Saldanha OL; Ke J; Müller W; Grabsch HI; Quirke P; Truhn D; Kather JN
    Lancet Digit Health; 2024 Jan; 6(1):e33-e43. PubMed ID: 38123254
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Development and characterization of NILK-2301, a novel CEACAM5xCD3 κλ bispecific antibody for immunotherapy of CEACAM5-expressing cancers.
    Seckinger A; Majocchi S; Moine V; Nouveau L; Ngoc H; Daubeuf B; Ravn U; Pleche N; Calloud S; Broyer L; Cons L; Lesnier A; Chatel L; Papaioannou A; Salgado-Pires S; Krämer S; Gockel I; Lordick F; Masternak K; Poitevin Y; Magistrelli G; Malinge P; Shang L; Kallendrusch S; Strein K; Hose D
    J Hematol Oncol; 2023 Dec; 16(1):117. PubMed ID: 38087365
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The Use of Cyclodextrin Inclusion Complexes to Increase the Solubility and Pharmacokinetic Profile of Albendazole.
    Ding Y; Zhang Z; Ding C; Xu S; Xu Z
    Molecules; 2023 Oct; 28(21):. PubMed ID: 37959715
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prognostic Impact of cancer Inflammation Prognostic Index for Non-small Cell Lung cancer.
    Motono N; Mizoguchi T; Ishikawa M; Iwai S; Iijima Y; Uramoto H
    Lung; 2023 Dec; 201(6):603-610. PubMed ID: 37906295
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Potential Signature Therapeutic Biomarkers TOP2A, MAD2L1, and CDK1 in colorectal cancer: A Systems Biomedicine-Based Approach.
    Priyamvada P; Ramaiah S
    Biochem Genet; 2024 Jun; 62(3):2166-2194. PubMed ID: 37884851
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Impact of posaconazole and diltiazem on pharmacokinetics of encorafenib, a BRAF V600 kinase inhibitor for melanoma and colorectal cancer with BRAF mutations.
    Hahn E; Chavira R; Wollenberg L; Tan W; Reddy MB
    Clin Transl Sci; 2023 Dec; 16(12):2675-2686. PubMed ID: 37837178
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. First-in-Humans PET Imaging of
    Li X; Ye J; Wang J; Quan Z; Li G; Ma W; Zhang M; Yang W; Wang J; Ma T; Kang F; Wang J
    J Nucl Med; 2023 Dec; 64(12):1880-1888. PubMed ID: 37827842
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 23.